These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 4324814)
1. Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin. Zbar B; Bernstein ID; Rapp HJ J Natl Cancer Inst; 1971 Apr; 46(4):831-9. PubMed ID: 4324814 [No Abstract] [Full Text] [Related]
2. [Stimulation of immunity to isologous transplantable hepatoma 22a and 46 using Freund's adjuvant in C3HA mice]. Orlov AB Vopr Onkol; 1970; 16(2):51-3. PubMed ID: 4314786 [No Abstract] [Full Text] [Related]
3. Enhanced tumor growth in animals pretreated with complete Freund's adjuvant. Meltzer MS; Leonard EJ J Natl Cancer Inst; 1973 Jan; 50(1):209-18. PubMed ID: 4348220 [No Abstract] [Full Text] [Related]
4. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine. Hanna MG; Peters LC Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374 [TBL] [Abstract][Full Text] [Related]
5. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG. Harmel RP; Zbar B; Rapp HJ J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537 [TBL] [Abstract][Full Text] [Related]
6. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor. Jessup JM; Riggs CW; Hanna MG Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084 [No Abstract] [Full Text] [Related]
7. Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy. Bartlett GL; Zbar B J Natl Cancer Inst; 1972 Jun; 48(6):1709-26. PubMed ID: 4341405 [No Abstract] [Full Text] [Related]
11. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis. Bartlett GL; Zbar B; Rapp HJ J Natl Cancer Inst; 1972 Jan; 48(1):245-57. PubMed ID: 4568964 [No Abstract] [Full Text] [Related]
12. Tumor-specific antigens: detection by local transfer of delayed skin hypersensitivity. Kronman BS; Rapp HJ; Borsos T J Natl Cancer Inst; 1969 Oct; 43(4):869-75. PubMed ID: 4310097 [No Abstract] [Full Text] [Related]
13. [Delayed type hypersensitivity in tumor-bearing rats]. Sobbe A; Haferkamp O Z Krebsforsch; 1967; 70(2):186-92. PubMed ID: 4298795 [No Abstract] [Full Text] [Related]
14. Detection of antigens of a new diethylnitrosamine-induced transplantable hepatoma by delayed hypersensitivity. Churchill WH; Rapp HJ; Kronman BS; Borsos T J Natl Cancer Inst; 1968 Jul; 41(1):13-29. PubMed ID: 4298551 [No Abstract] [Full Text] [Related]
15. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets. Zbar B; Rapp HJ; Ribi EE J Natl Cancer Inst; 1972 Mar; 48(3):831-5. PubMed ID: 4333775 [No Abstract] [Full Text] [Related]
16. A guinea pig model for tumor immunology. A summary. Rapp HJ Isr J Med Sci; 1973 Mar; 9(3):366-74. PubMed ID: 4122812 [No Abstract] [Full Text] [Related]
17. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG). Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524 [No Abstract] [Full Text] [Related]
18. Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration. Churchill WH; Zbar B; Belli JA; David JR J Natl Cancer Inst; 1972 Feb; 48(2):541-9. PubMed ID: 4119886 [No Abstract] [Full Text] [Related]
19. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG. Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147 [No Abstract] [Full Text] [Related]